231 related articles for article (PubMed ID: 23054995)
1. From multidrug-resistant to extensively drug-resistant tuberculosis in Lisbon, Portugal: the stepwise mode of resistance acquisition.
Perdigão J; Macedo R; Silva C; Machado D; Couto I; Viveiros M; Jordao L; Portugal I
J Antimicrob Chemother; 2013 Jan; 68(1):27-33. PubMed ID: 23054995
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of extensively drug-resistant Mycobacterium tuberculosis strains in Lisbon, Portugal.
Perdigão J; Macedo R; Malaquias A; Ferreira A; Brum L; Portugal I
J Antimicrob Chemother; 2010 Feb; 65(2):224-7. PubMed ID: 20028780
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
Oudghiri A; Karimi H; Chetioui F; Zakham F; Bourkadi JE; Elmessaoudi MD; Laglaoui A; Chaoui I; El Mzibri M
BMC Infect Dis; 2018 Feb; 18(1):98. PubMed ID: 29486710
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterial interspersed repetitive unit typing and mutational profile for multidrug-resistant and extensively drug-resistant tuberculosis surveillance in Portugal: a 3-year period overview.
Silva C; Perdigão J; Jordão L; Portugal I
Int J Antimicrob Agents; 2014 Dec; 44(6):546-51. PubMed ID: 25270633
[TBL] [Abstract][Full Text] [Related]
5. Tuberculosis drug-resistance in Lisbon, Portugal: a 6-year overview.
Perdigão J; Macedo R; Silva C; Pinto C; Furtado C; Brum L; Portugal I
Clin Microbiol Infect; 2011 Sep; 17(9):1397-402. PubMed ID: 20731680
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of mutations associated with resistance to second line drugs in Mycobacterium tuberculosis patients from Casablanca, Morocco.
Momen G; Aainouss A; Lamaammal A; Chettioui F; Blaghen M; Messoudi M; Belghmi K; Mouslim J; El Mzibri M; El Messaoudi MD; Khyatti M; Chaoui I
Rev Inst Med Trop Sao Paulo; 2021; 63():e19. PubMed ID: 33787739
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from high prevalence tuberculosis states in Mexico.
Juarez-Eusebio DM; Munro-Rojas D; Muñiz-Salazar R; Laniado-Laborín R; Martinez-Guarneros JA; Flores-López CA; Zenteno-Cuevas R
Infect Genet Evol; 2017 Nov; 55():384-391. PubMed ID: 27637930
[TBL] [Abstract][Full Text] [Related]
8. Multidrug-resistant tuberculosis in Lisbon, Portugal: a molecular epidemiological perspective.
Perdigão J; Macedo R; João I; Fernandes E; Brum L; Portugal I
Microb Drug Resist; 2008 Jun; 14(2):133-43. PubMed ID: 18573039
[TBL] [Abstract][Full Text] [Related]
9. High-level resistance to isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with inhA double mutations.
Machado D; Perdigão J; Ramos J; Couto I; Portugal I; Ritter C; Boettger EC; Viveiros M
J Antimicrob Chemother; 2013 Aug; 68(8):1728-32. PubMed ID: 23539241
[TBL] [Abstract][Full Text] [Related]
10. Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables.
Kambli P; Ajbani K; Nikam C; Sadani M; Shetty A; Udwadia Z; Georghiou SB; Rodwell TC; Catanzaro A; Rodrigues C
Int J Mycobacteriol; 2016 Mar; 5(1):1-6. PubMed ID: 26927983
[TBL] [Abstract][Full Text] [Related]
11. Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Bakuła Z; Napiórkowska A; Kamiński M; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J; Jagielski T
J Microbiol Immunol Infect; 2016 Jun; 49(3):439-44. PubMed ID: 26117528
[TBL] [Abstract][Full Text] [Related]
12. First Insight Into the Fluoroquinolone and Aminoglycoside Resistance of Multidrug-Resistant
Varghese B; Al-Hajoj S
Am J Trop Med Hyg; 2017 May; 96(5):1066-1070. PubMed ID: 28500800
[TBL] [Abstract][Full Text] [Related]
13. Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016).
Kateete DP; Kamulegeya R; Kigozi E; Katabazi FA; Lukoye D; Sebit SI; Abdi H; Arube P; Kasule GW; Musisi K; Dlamini MG; Khumalo D; Joloba ML
BMC Pulm Med; 2019 Jul; 19(1):124. PubMed ID: 31291943
[TBL] [Abstract][Full Text] [Related]
14. Genomic sequence based scanning for drug resistance-associated mutations and evolutionary analysis of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis.
Liu CH; Li HM; Lu N; Wang Q; Hu YL; Yang X; Hu YF; Woo PC; Gao GF; Zhu B
J Infect; 2012 Nov; 65(5):412-22. PubMed ID: 22728171
[TBL] [Abstract][Full Text] [Related]
15. Unraveling Mycobacterium tuberculosis genomic diversity and evolution in Lisbon, Portugal, a highly drug resistant setting.
Perdigão J; Silva H; Machado D; Macedo R; Maltez F; Silva C; Jordao L; Couto I; Mallard K; Coll F; Hill-Cawthorne GA; McNerney R; Pain A; Clark TG; Viveiros M; Portugal I
BMC Genomics; 2014 Nov; 15(1):991. PubMed ID: 25407810
[TBL] [Abstract][Full Text] [Related]
16. Impact of
Bablishvili N; Tukvadze N; Shashkina E; Mathema B; Gandhi NR; Blumberg HM; Kempker RR
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630205
[TBL] [Abstract][Full Text] [Related]
17. Novel multiplex allele-specific PCR assays for the detection of resistance to second-line drugs in Mycobacterium tuberculosis.
Evans J; Segal H
J Antimicrob Chemother; 2010 May; 65(5):897-900. PubMed ID: 20185419
[TBL] [Abstract][Full Text] [Related]
18. Frequency of first and second-line drug resistance-associated mutations among resistant Mycobacterium tuberculosis clinical isolates from São Paulo, Brazil.
Matsui T; Pinhata JMW; Rabello MCDS; Brandão AP; Ferrazoli L; Leão SC; Viana-Niero C; Oliveira RS
Mem Inst Oswaldo Cruz; 2020; 115():e200055. PubMed ID: 32401997
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of amikacin, kanamycin and capreomycin resistance in M/XDR-TB strains isolated in Thailand.
Sowajassatakul A; Prammananan T; Chaiprasert A; Phunpruch S
BMC Microbiol; 2014 Jun; 14():165. PubMed ID: 24953243
[TBL] [Abstract][Full Text] [Related]
20. Extensively drug-resistant tuberculosis in Myanmar: burden and mutations causing second-line drug resistance.
Ei PW; Aung WW; Nyunt WW; Swe TL; Htwe MM; Win SM; Aung ST; Chang CL; Lee HY; Lee JS
Int J Tuberc Lung Dis; 2018 Jan; 22(1):47-53. PubMed ID: 29297425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
